Ashweta Sahni

Ashweta Sahni's research focuses on designing and understanding cyclic and bicyclic peptides that can cross cell membranes to deliver therapeutic molecules inside cells, including inhibitors targeting cancer-related proteins. This work spans peptide chemistry, drug delivery mechanisms (such as escaping cellular compartments called endosomes), and anti-cancer compound development. The research combines organic chemistry synthesis with biological evaluation of how these peptides function inside cells.

Publication output was relatively active between 2018 and 2021 but has slowed considerably since 2022, with sparse output in recent years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026